Juli Miller | IR |
James Noble | CEO |
Adrian Rawcliffe | Incoming CEO |
Rafael Amado | President, R&D |
Waleed Abdel-Naby | SunTrust Robinson Humphrey |
Kelsey Goodwin | Guggenheim Securities |
Marc Frahm | Cowen |
Keith Tapper | Citi |
Jonathan Chang | SVB Leerink |
Jim Birchenough | Wells Fargo |
Tony Butler | Roth Capital Partners |
Good morning, and welcome to the Second Quarter of 2019 Adaptimmune Earnings Conference Call. My name is Carla, and I will be your conference operator today. [Operator instructions] And now I would like to turn the call over to Juli Miller. Go ahead, please.
Good morning, and welcome to Adaptimmune's conference call to discuss our second-quarter 2019 financial results and other business update.